ArticleJournal of muscle research and cell motility2015
Important announcement: a rational nomenclature for tropomyosin variants.
Article in Journal of muscle research and cell motility, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Comment on
Authors and funding
1 author.
Funding
Abstract
In an article in this edition of the Journal of Muscle Research and Cell Motility, Geeves, Hitchcock-DiGregori and Gunning present a nomenclature founded on the gene and exon structure of tropomyosin that is both clear and unambiguous. Moreover, the authors have ensured that the new names are linked with their sequences in the NCBI database, thus eliminating the uncertainty of linking a protein isoform with its sequence. This nomenclature system has been planned with the support of all the major labs that work with tropomyosin. We recommend that all researchers take note of this scheme and use it.
Indexed as
Identifiers
25361644What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.